JP2019055949A5 - - Google Patents

Download PDF

Info

Publication number
JP2019055949A5
JP2019055949A5 JP2018177525A JP2018177525A JP2019055949A5 JP 2019055949 A5 JP2019055949 A5 JP 2019055949A5 JP 2018177525 A JP2018177525 A JP 2018177525A JP 2018177525 A JP2018177525 A JP 2018177525A JP 2019055949 A5 JP2019055949 A5 JP 2019055949A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
monoclonal antibody
functional fragment
plasmin
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018177525A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019055949A (ja
JP6971946B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019055949A publication Critical patent/JP2019055949A/ja
Publication of JP2019055949A5 publication Critical patent/JP2019055949A5/ja
Application granted granted Critical
Publication of JP6971946B2 publication Critical patent/JP6971946B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018177525A 2017-09-21 2018-09-21 反応抑制的抗体による特異的プラスミン不活性化 Active JP6971946B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762561332P 2017-09-21 2017-09-21
US62/561,332 2017-09-21

Publications (3)

Publication Number Publication Date
JP2019055949A JP2019055949A (ja) 2019-04-11
JP2019055949A5 true JP2019055949A5 (https=) 2021-10-28
JP6971946B2 JP6971946B2 (ja) 2021-11-24

Family

ID=63678447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018177525A Active JP6971946B2 (ja) 2017-09-21 2018-09-21 反応抑制的抗体による特異的プラスミン不活性化

Country Status (3)

Country Link
US (1) US11066482B2 (https=)
EP (1) EP3459974B1 (https=)
JP (1) JP6971946B2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4051714A4 (en) * 2019-10-28 2023-11-22 Monash University ANTIBODIES FOR BINDING PLASMIN
WO2023213869A1 (en) * 2022-05-04 2023-11-09 Rheinische Friedrich-Wilhelms-Universität Bonn Plasmin-binding vhhs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004045558A2 (en) 2002-11-18 2004-06-03 President And Fellows Of Harvard College Compositions and methods for treating thrombotic disorders
AU2012304635B2 (en) * 2011-09-06 2017-08-31 Translational Sciences Inc. SerpinF2-binding molecules and methods of use
US10160813B2 (en) 2013-01-22 2018-12-25 University Of Tennessee Research Foundation Tissue plasminogen activator antibodies and methods of use
US9908944B2 (en) 2013-07-15 2018-03-06 Novo Nordisk A/S Antibodies that bind urokinase plasminogen activator

Similar Documents

Publication Publication Date Title
JP2020516240A5 (https=)
JP2010536384A5 (https=)
HRP20191999T1 (hr) Monoklonska protutijela anti-faktora xi i postupci njihove uporabe
RU2014143785A (ru) Фармацевтическая композиция для лечения и/или предотвращения рака печени
RU2014143784A (ru) Фармацевтическая композиция для лечения и/или предотвращения рака желчного пузыря
RU2010119521A (ru) Антитела, связывающие il-4 и/или il-13, и их применение
RU2014108047A (ru) Фармацевтическая композиция для лечения и/или профилактики рака поджелудочной железы
JP2017113019A5 (https=)
JP2018502051A5 (https=)
HRP20201733T1 (hr) Postupci liječenja stanja povezanih s aktivacijom komplementa ovisnim o masp-2
RU2019118359A (ru) Антитело к cd73 человека
EA032189B9 (ru) Изолированные человеческие моноклональные антитела против ингибитора пути тканевого фактора (tfpi) и фармацевтическая композиция, содержащая их
JP2014533239A5 (https=)
JP2020526478A5 (https=)
JP2020502271A5 (https=)
ME02371B (me) Sastojci i postupci za dijagnstikovanje i tretman raka
JP2018508483A5 (https=)
JP2017536341A5 (https=)
GEP20115324B (en) Tweak binding antibodies
JP2010516708A5 (https=)
JP2018512124A5 (https=)
JP2015511221A5 (https=)
JP2018507220A5 (https=)
ZA202305217B (en) Anti-tigit antibody, and pharmaceutical composition and use thereof
JP2023015301A5 (https=)